Unitedhealth Group INC Form 4 insider transactions

UnitedHealth Group's EVP & Chief People Officer, Erin McSweeney, reported the disposition of common stock shares to cover tax liabilities.

UnitedHealth Group's EVP & Chief Legal Officer, Christopher R. Zaetta, disposed of 443.287 shares of common stock to cover tax liabilities.

Patrick H. Conway, CEO of Optum, reported the disposition of UnitedHealth Group common stock to cover tax liabilities.

Timothy J. Noel, CEO of UnitedHealthcare, reported the disposition of UnitedHealth Group common stock to cover tax withholding obligations.

UnitedHealth Group's Chief Accounting Officer, Thomas E. Roos, reported the disposition of common stock, likely for tax purposes, on February 20, 2026.

UnitedHealth Group Director Paul R. Garcia acquired additional common stock and deferred stock units as part of his regular quarterly compensation.

UnitedHealth Group Director Timothy P. Flynn acquired 285 deferred stock units as part of his regular quarterly compensation, increasing his direct beneficial ownership.

UnitedHealth Group director Kristen Gil received 168 shares of common stock as part of her regular quarterly compensation.

UnitedHealth Group director John H. Noseworthy acquired 261 shares of common stock as part of his regular quarterly compensation.

UnitedHealth Group director Valerie Montgomery Rice acquired 279 deferred stock units as part of her regular quarterly compensation, vesting immediately but restricted until board service completion.

UnitedHealth Group Director Scott Gottlieb acquired 125 deferred stock units as part of his regular quarterly compensation, vested immediately.

UnitedHealth Group Director Michele J. Hooper acquired 168 deferred stock units as part of her regular quarterly compensation, increasing her beneficial ownership to 41,294 shares.

UnitedHealth Group Director Frederick William McNabb III acquired 316 deferred stock units as part of his regular quarterly compensation.

UnitedHealth Group director Charles D. Baker acquired 279 deferred stock units as part of his regular quarterly compensation.

UnitedHealth Group CEO Stephen J. Hemsley reported gifting 55,000 shares of common stock, maintaining significant beneficial ownership.

UnitedHealth Group's CEO, Timothy J. Noel, acquired 44.329 shares of common stock through dividend equivalents on restricted stock units.

UnitedHealth Group Director Valerie C. Montgomery Rice M.D. acquired 43 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group's EVP & Chief People Officer, Erin McSweeney, acquired 38.566 shares of common stock as dividend equivalents on restricted stock units.

UnitedHealth Group Director Charles D. Baker acquired 11 shares of common stock on December 16, 2025, through dividend equivalents on vested deferred stock units.

UnitedHealth Group CEO Stephen J. Hemsley acquired 52 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Frederick William McNabb III acquired 53 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director John H. Noseworthy acquired 43 shares of common stock on December 16, 2025, through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Kristen Gil acquired 7 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group's EVP & Chief Legal Officer, Christopher R. Zaetta, acquired 44.528 shares of common stock as dividend equivalents on restricted stock units.

Patrick H. Conway, Chief Executive Officer of Optum, acquired 67.721 shares of UnitedHealth Group common stock through dividend equivalents on restricted stock units.

UnitedHealth Group's CFO, Wayne S. DeVeydt, acquired 70.042 shares of common stock through dividend equivalents on restricted stock units.

UnitedHealth Group Director Timothy Flynn reported the acquisition of 65 common shares as dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Michele J. Hooper acquired 249 shares of common stock through dividend equivalents on vested deferred stock units.

UnitedHealth Group Director Paul R. Garcia increased his beneficial ownership of common stock through the acquisition of dividend equivalents on vested deferred stock units.

UnitedHealth Group's Chief Accounting Officer, Thomas E. Roos, acquired 23.408 shares of common stock as dividend equivalents on restricted stock units.